missing translation for 'onlineSavingsMsg'
Learn More

Stemcell Technologies Inc ImmunoCult™ Human CD3/CD28/CD2 T Cell Activator, Size: 2 mL

Catalog No. NC0957994
Encompass

Achieve robust activation and expansion of T cells in the absence of magnetic beads, feeder cells, or antigens. This products gentle activation stimulus ensures a high viability of activated T cells, which can be further expanded in ImmunoCult™-XF T Cell Expansion Medium (Catalog #10981) or other media for culturing human T cells. ImmunoCult™ Human CD3/CD28/CD2 T Cell Activator consists of soluble tetrameric antibody complexes that bind to and cross-link CD3, CD28, and CD2 cell surface ligands, thereby providing the required primary and co-stimulatory signals for T cell activation. This product is designed for cell therapy research applications, but may be qualified for use as an ancillary material (AM) following the framework outlined in USP<1043>. Contact STEMCELL Technologies to learn how we can work with you to qualify this reagent as an AM under an approved investigational new drug (IND) or clinical trial application (CTA).

Catalog No. NC0957994 Supplier Stemcell Technologies Inc Supplier No. 10970

Please call Customer Service at 1-800-234-7437 or send an email to help@thermofisher.com for assistance.

Achieve robust activation and expansion of T cells in the absence of magnetic beads, feeder cells, or antigens. This products gentle activation stimulus ensures a high viability of activated T cells, which can be further expanded in ImmunoCult™-XF T Cell Expansion Medium (Catalog #10981) or other media for culturing human T cells. ImmunoCult™ Human CD3/CD28/CD2 T Cell Activator consists of soluble tetrameric antibody complexes that bind to and cross-link CD3, CD28, and CD2 cell surface ligands, thereby providing the required primary and co-stimulatory signals for T cell activation. This product is designed for cell therapy research applications, but may be qualified for use as an ancillary material (AM) following the framework outlined in USP<1043>. Contact STEMCELL Technologies to learn how we can work with you to qualify this reagent as an AM under an approved investigational new drug (IND) or clinical trial application (CTA).